P. Olshan

Circulating tumor DNA for early relapse detection and monitoring disease status in patients with early-stage pancreatic adenocarcinoma

Background Pancreatic adenocarcinoma (PDAC) is one of the most aggressive cancer histologies, as evidenced by high recurrence rate (85%) and poor 5-year overall survival...

M. Abdelrahim ;

A. Esmail ;

T. Katz ;

S. Sharma , MD;

E. Kalashnikova ;

Manoj Malhotra , MD;

P. Olshan ;

P. Billings ;

A. Aleshin ;

06/28/2021

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

P. Olshan

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products